.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Express Scripts
US Department of Justice
Daiichi Sankyo
Baxter
Federal Trade Commission
UBS
Merck
Boehringer Ingelheim

Generated: December 18, 2017

DrugPatentWatch Database Preview

Lidocaine; tetracaine - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine; tetracaine and what is the scope of lidocaine; tetracaine patent protection?

Lidocaine; tetracaine
is the generic ingredient in two branded drugs marketed by Taro Pharms and Galen Specialty, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine; tetracaine has twenty-two patent family members in eleven countries.

There are twenty-nine drug master file entries for lidocaine; tetracaine. Four suppliers are listed for this compound.

Summary for lidocaine; tetracaine

Pharmacology for lidocaine; tetracaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005RXYesYes► Subscribe► SubscribeY► Subscribe
Taro PharmsPLIAGLISlidocaine; tetracaineCREAM;TOPICAL021717-001Jun 29, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine; tetracaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Taro PharmsPLIAGLISlidocaine; tetracaineCREAM;TOPICAL021717-001Jun 29, 2006► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine; tetracaine

Country Document Number Estimated Expiration
China101219108► Subscribe
China1376043► Subscribe
European Patent Office1702597► Subscribe
Japan2004510454► Subscribe
World Intellectual Property Organization (WIPO)0103625► Subscribe
Denmark1244401► Subscribe
Germany60032021► Subscribe
Japan2012246315► Subscribe
European Patent Office1244401► Subscribe
China100367927► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Farmers Insurance
Novartis
Citi
US Army
QuintilesIMS
Fuji
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot